Posts

Showing posts from September, 2016
Image
Cost Of Cancer, Diabetes, Blood Pressure Drugs Reduced By Around 25% Prices of 56 important medicines used in treatment of cancer , diabetes, bacterial infections and blood pressure have been capped by the government, thereby reducing the cost by an average of around 25 per cent. Products of major pharmaceuticals firms - including Abbott Healthcare, Cipla, Lupin, Alembic, Alkem Laboratories, Novartis, Biocon, Intas Pharmaceuticals, Hetero Healthcare and erstwhile Ranbaxy (now Sun Pharmaceutical Industries) - will be affected by the new price cap announced by drug price regulator NPPA (National Pharmaceutical Pricing Authority). The capping of the prices of 56 scheduled formulations of Schedule-I is being carried out under the Drugs (Price Control) Amendment Order, 2016, and retail prices of eight formulations under the Drugs (Prices Control) Order, 2013. The government fixes the prices of essential drugs based on the simple average of all medicines in a particular thera
Image
Generic Erlotinib Cancer Medicine What is Erlotinib # Erlotinib is a targeted therapy. # Erlotinib is classified as a epidermal growth factor receptor (EGFR) inhibitor - protein-tyrosine kinase inhibitor. Erlotinib comes in form of tablets and available under 100 mg and 150 mg strength under various brands from indian and multinational manufacturers. Uses of Erlotinib Erlotinib is used for:- Treating certain types of advanced or metastatic # lungcancer . Treating certain types of # pancreaticcancer in combination with another medicine (gemcitabine). Most Common Side Effects of Erlotinib Diarrhea Weakness Rash Cough Shortness of breath Loss of appetite (not wanting to eat) Fatigue (feeling very tired) Nausea If any of these effects persist or worsen, notify your doctor or pharmacist promptly. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. Im